From biomarker ranking to decision-grade prevention in metabolic syndrome: the next translational step after NHANES-based marker comparison
Indian Journal of Clinical Biochemistry · 15.06.2026
DOI: 10.1007/s12291-026-01426-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Clinical Biochemistry, online erschienen am 15.06.2026. Verfasst von Mulavagili Srikanth und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Srikanth, M., Priya, S. H., & Jayarajan, D. (2026). From biomarker ranking to decision-grade prevention in metabolic syndrome: the next translational step after NHANES-based marker comparison. Indian Journal of Clinical Biochemistry. https://doi.org/10.1007/s12291-026-01426-4
Vancouver
Srikanth M, Priya SH, Jayarajan D. From biomarker ranking to decision-grade prevention in metabolic syndrome: the next translational step after NHANES-based marker comparison. Indian Journal of Clinical Biochemistry. 2026. doi:10.1007/s12291-026-01426-4
BibTeX
@article{Srikanth2026,
author = {Srikanth, Mulavagili and Priya, S. Hari and Jayarajan, Devadass},
title = {From biomarker ranking to decision-grade prevention in metabolic syndrome: the next translational step after NHANES-based marker comparison},
journal = {Indian Journal of Clinical Biochemistry},
year = {2026},
doi = {10.1007/s12291-026-01426-4}
}
EUVIMED